A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection
Clinical trial NCT04602000 · COMPLETED
Trial details
- NCT number
- NCT04602000
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2021-05-21
- Enrollment
- 1642
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.